Company Filing History:
Years Active: 2025
Title: Jacek Olozak: Innovator in Therapeutic Applications
Introduction
Jacek Olozak is a notable inventor based in Łódź, Poland. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic applications related to chitinase-like protein YKL-40. His innovative work has the potential to impact various medical treatments and diagnostics.
Latest Patents
Jacek Olozak holds a patent for YKL-40 inhibitors and their therapeutic applications. The patent discloses assays for screening active compounds that interfere with the interaction between chitinase-like protein YKL-40 and chitin oligomers, as well as with heparan sulfate. Additionally, the patent identifies active compounds that serve as inhibitors of YKL-40, detailing their therapeutic applications and their use in biosensors for measuring YKL-40 levels in biological samples. He has 1 patent to his name.
Career Highlights
Olozak is currently associated with Molecure S.A., where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions in the field of biotechnology, contributing to the understanding and treatment of various diseases.
Collaborations
Some of his notable coworkers include Łukasz Krzemiński and Wojciech J Czestkowski. Their collaborative efforts enhance the research environment and foster innovation within their projects.
Conclusion
Jacek Olozak's contributions to the field of biotechnology, particularly through his patent on YKL-40 inhibitors, highlight his role as an innovator in therapeutic applications. His work continues to pave the way for advancements in medical science.